Zota Health Care's Q4 FY 2025-26 Quarterly Results

Result Summary

• Zota Health Care Ltd reported a 15.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 69.3%.
• Its expenses for the quarter were up by 9.5% QoQ and 65.9% YoY.
• The net profit decreased 51.2% QoQ and increased 12.2% YoY.
• The earnings per share (EPS) of Zota Health Care Ltd declined at 4.13 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Zota Health Care Ltd is a company that specializes in the pharmaceutical industry, focusing on the production and marketing of healthcare products. It offers a range of pharmaceutical formulations, nutraceuticals, and ayurvedic products. As of the latest data, the company has been active in expanding its market reach and product offerings, although specific recent developments are not detailed in the provided information. The company operates within a competitive industry that is sensitive to regulatory changes and market demands, which can impact its financial performance.

Revenue

For the fourth quarter of the fiscal year 2026 (Q4FY26), Zota Health Care Ltd reported a total income of ₹166.38 crores. This represents an increase of 15.0% from the previous quarter (Q3FY26), where the total income was ₹144.67 crores. Year-over-year, the company observed a substantial growth of 69.3% in total income compared to Q4FY25, where it was ₹98.28 crores. The upward trend in revenue suggests a positive trajectory in the company's sales or services offered during this period.

Profitability

In terms of profitability, Zota Health Care Ltd recorded a loss before tax of ₹26.42 crores in Q4FY26. This is a slight increase from the loss of ₹25.95 crores in the previous quarter, reflecting a 1.8% change quarter-over-quarter. Compared to the same quarter in the previous year (Q4FY25), when the loss before tax was ₹14.30 crores, there is an increase of 84.8% year-over-year. The profit after tax for Q4FY26 was a negative ₹14.46 crores, which shows an improvement from the previous quarter's loss after tax of ₹29.64 crores, equating to a change of -51.2%. However, there is a 12.2% increase in loss compared to Q4FY25's figure of ₹12.89 crores. The earnings per share (EPS) also reflect this trend, with a value of -₹4.13 in Q4FY26, compared to -₹9.21 in Q3FY26 and -₹4.28 in Q4FY25, showing changes of -55.2% quarter-over-quarter and -3.5% year-over-year.

Operating Metrics

Zota Health Care Ltd's total expenses for Q4FY26 amounted to ₹186.80 crores, which reflects a 9.5% increase from the previous quarter's expenses of ₹170.62 crores. Compared to the same period in the previous fiscal year (Q4FY25), where expenses were ₹112.59 crores, there is a year-over-year increase of 65.9%. The tax expense for Q4FY26 was recorded as a negative ₹11.96 crores, which contrasts with the ₹3.69 crores tax recorded in Q3FY26, showing a significant quarterly change of -424.1%. This also marks a substantial year-over-year change of 742.3% when compared to Q4FY25's tax of -₹1.42 crores. These operating metrics illustrate the company's cost management and taxation impact during the quarter.